Pharmaceutical companies are increasingly looking to 'managed entry' programmes to build strong relationships with NHS customers and ensure new products …
Key decision makers will shape the biosimilars landscapeWith many biologic drugs used to treat increasingly common diseases such as cancer …
NICE is set to recommend Roche's lung cancer treatment Tarceva after the company agreed to lower the drug's price. The …
More exercise and healthier eating are at the core of the government's new anti-obesity initiative, called Change4Life. Billed this week …
GlaxoSmithKline has announced plans to close its manufacturing site in Dartford in the UK, with operations being phased out over …
AstraZeneca's statin Crestor made national headlines this week when it was shown to dramatically reduce major cardiovascular events. New data …
GlaxoSmithKline has withdrawn the US application for its restless legs syndrome treatment Solzira. The company, along with co-developer XenoPort, is …
The government is working with the pharma industry on new 'flexible pricing' arrangements, even though revisions to the existing PPRS …
Results from clinical trials are the very lifeblood of the pharmaceutical industry, representing the frontline in the search for new …
MedImmune, AstraZeneca's biotech arm, has opened a new R&D facility in Cambridge as part of a major expansion of its …
PCTs will have to make major and unplanned cuts to their drugs budgets and divert the money to shore up …
The UK wants to improve access to information on health and social care by launching a new 'seal of approval' …
The PPRS deal agreed in principle this summer has been now thrown into confusion by government, with its launch at …
British pharma is free to provide necessary and sufficient information to patients about its drugs, and is an example to …
Amgen says two of its pipeline products are potential blockbusters in three indications. The company is keen to reaffirm its …
A US survey has shown that concern about the high cost of medicines means that many patients are not taking …
Contract research organisation Patheon has opened a new European head office in Zug, Switzerland, near Zurich. The new headquarters will …
Patient groups are calling on a pharmaceutical company to reach a compromise with NICE over a bone marrow cancer drug. …
How did you arrive at your current position?A long story. I started in Mobil Oil in Denmark after graduating from …
Is there an alternative to HRT for menopausal relief?Sales of hormone replacement therapy have declined recently due to safety concerns, …